Therefore, CD4, CD8, Foxp3, GrB, IL10, and CD68 immune cell markers were studied in order to explore if differences around EBV-infected CG cells and EBV+ tumor cells derived from GC cells could be involved in the malignant transformation. The gene discussed is CD68; the disease is neoplasm.